Presentaciones Orales   

Presentación 1         
Presidente - Verónica Mezzano   

26 de abril, 11.00 a 12.00 hrs. SALON III-A (1er. piso)       
           
EVALUACION DE CITOQUINAS Th-17 EN PACIENTES CON ESPONDILOARTRITIS COMPARADO CON UN MODELO DE INFECCION BACTERIANA   
Romero-Sánchez C, Londoño J, Jaimes DA, Bello JM, Mora A, Castellanos J, De Avila J, Lafaurie G, Yu D, Valle-Oñate R.

OPPOSING EFFECT OF MESENCHYMAL STEM CELLS ON TH1 AND TH17 CELL POLARIZATION ACCORDING TO THE STATE OF CD4+ T CELL ACTIVATION
Carrion F, Nova F, Luz P, Apablaza F, Campos C, and Figueroa F.

TOLERANCIA ANTÍGENO ESPECÍFICA MEDIANTE EL EMPLEO DE VACUNAS DE DNA QUE CODIFICAN PARA EL AUTOANTÍGENO SM E IL-10 EN UN MODELO MURINO DE LUPUS
Martín B, Minoru S, Martínez E, Arana V, Muñoz J, Maldonado M, Hernández R, Vázquez Del Mercado M.

DOCUMENTATION OF FEWER GOUT FLARES AFTER LONG-TERM URATE LOWERING THERAPY
Becker, MA, Schumacher HR, Chohan S, MacDonald P, Hunt B, Jackson RL
           
Presentación 2           
Presidente - Sonia Kaliski  

27 de abril, 11:00 a 12:00 hrs. SALON III-A (1er. piso)       
           
FUNCION DIASTÓLICA CON IMAGEN DOPPLER TISULAR EN PACIENTES CON LES SIN FACTORES DE RIESGO TRADICIONAL PARA ENFERMEDAD CORONARI   
Mendoza-Pinto C, Garcia-Carrasco M, Jimenez-Hernández, Sanchez-Perez R, Sanchez-Porras R, Ramirez-Guillen F, Pazaran-Zanella O, Perez-Alva J.

TREATMENT OF ADULT JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH TNF BLOCKERS AND EFFECT OF SWITCHING TO A SECOND ANTI-TNF AGENT
Jarosova K,  Chroust K,  Buresova L, Vencovsky J.

REDUCTION OF DISEASE ACTIVITY, FLARES, AND STEROID USE BY BELIMUMAB, A BLyS-SPECIFIC INHIBITOR, IN PATIENTS WITH SEROPOSITIVE SLE: BLISS-52 STUDY
Gallacher A, Guzman R, Leon MG, Levy RA, Radominski S, Jimenez R, Spindler A, Scotton A, Jaller J, Pineda L, Jhong ZJ, Freimuth W, BLISS-52 Study Grp

FOUR-YEAR EXPERIENCE WITH BELIMUMAB, A BLyS-SPECIFIC INHIBITOR, IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): LBSL02/99 STUDY
Furie RA, Merrill J, Wallace D, Ginzler E, Stohl W, Chatham W, McCune J, Weinstein A, Petri M, Pineda L, Zhong ZJ, Klein J, Freimuth W.
           
Presentación 3       
Presidente - Aurelio Carvallo   

27 de abril, 18:30 a 19:30 hrs. SALON VI  (2do. piso)
           
LONG-TERM EFFICACY OF TOCILIZUMAB UP TO 3.5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM ANALYSIS OF LONG-TERM EXTENSION STUDIES   
Calvo A, Siri D, Saavedra M, Kissel K, Alecock E, Smolen J.

SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM ANALYSIS UP TO 3.5 YEARS OF TREATMENT IN LONG-TERM EXTENSION STUDIES
Tate G, Scali J, Monge P, Kissel K, Alecock E, van Vollenhoven RF.

TOCILIZUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN RA PATIENTS WITH INADEQUATE RESPONSE TO PRIOR DMARDs: OPTION/TOWARD POOLED ANALYSIS
Guerra G, Smolen J, Genovese M, Kissel K, Mysler E.

TOCILIZUMAB IN RHEUMATOID ARTHRITIS (RA): LITHE 2-YEAR RESULTS
Burgos-Vargas R, Fleischmann R, Castelar Pinheiro G, Andrade L, Irazoque F, Kissel K, Alecock E, Kremer J.

Presentación 4
Presidente - Carol Pérez   

27 de abril, 18:30 a 19:30 hrs. SALON VII (2do. piso)
           
TOCILIZUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN RA PATIENTS WITH INADEQUATE RESPONSE TO PRIOR ANTI-TNF THERAPY: THE RADIATE STUDY
Sanchez Ortiz A, Kissel K, Alecock E, Emery P.

EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO ANTI-TNF THERAPY BY NUMBER OF PRIOR ANTI-TNF THERAPIES USED
Schiff M, Le Bars M, Gaillez C, Wu G, Poncet C, Genovese MC.

ERA PATIENTS TREATED WITH ABATACEPT AND MTX HAVE A HIGHER CHANCE OF IMPROVEMENTS IN SIGNS, SYMPTOMS AND PHYSICAL FUNCTION THAN TREATED WITH MTX ALONE
Yazici Y, Moniz Reed D, Covucci A, Becker JC, Westhovens R.

DISEASE REMISSION IS ACHIEVED AT 2YEARS IN OVER HALF OF MTX NAIVE PATIENTS WITH EARLY EROSIVE RA TREATED WITH ABATACEPT PLUS MTX: AGREE TRIAL
Westhovens R, Robles M, Nayiager S, Wollenhaupt J, Durez P, Gomez R J, Grassi W, Haraoui B, Shergy W, Park SH. Genant H. Peterfy C. Bathon J. Becker J

PANLAR 2010: Resúmenes aceptados

Descargue los resúmenes de los trabajos científicos presentados en PANLAR 2010...ver más >>

XVI Congreso Panamericano de Reumatología

Sitio web oficial del Congresover más >>